TY - STD TI - US Food Drug Administration 2013. Center for Drug Evaluation and Research. Guidance for industry. Acute bacterial skin and skin structure infections developing drugs for treatment. Available at http://www.fda.gov/downloads/Drugs/Guidances/ucm071185.pdf UR - http://www.fda.gov/downloads/Drugs/Guidances/ucm071185.pdf ID - ref1 ER - TY - BOOK PY - 2005 DA - 2005// TI - CREST guidelines on the management of cellulitis in adults PB - DHSS CY - Northern Ireland ID - ref2 ER - TY - JOUR AU - Dong, S. L. AU - Kelly, K. AU - Oland, R. C. AU - Holroyd, B. R. AU - Rowe, B. H. PY - 2001 DA - 2001// TI - ED management of cellulitis: a review of five urban centers JO - Am J Emerg Med VL - 19 ID - Dong2001 ER - TY - JOUR AU - Schrock, J. W. AU - Laskey, S. AU - Cydulka, R. K. PY - 2008 DA - 2008// TI - Predicting observation unit treatment failures in patients with skin and soft tissue infections JO - Int J Emerg Med VL - 1 ID - Schrock2008 ER - TY - JOUR AU - Ansari, F. AU - Erntell, M. AU - Goossens, H. AU - Davey, P. PY - 2009 DA - 2009// TI - The European surveillance of antimicrobial consumption (ESAC) point-prevalence survey of antibacterial use in 20 European hospitals in 2006 JO - Clin Infect Dis VL - 49 ID - Ansari2009 ER - TY - JOUR AU - Quirke, M. AU - O’Sullivan, R. AU - McCabe, A. AU - Ahmed, J. AU - Wakai, A. PY - 2014 DA - 2014// TI - Are two penicillins better than one? A systematic review of oral flucloxacillin and penicillin V versus oral flucloxacillin alone for the emergency department treatment of cellulitis JO - Eur J Emerg Med VL - 21 ID - Quirke2014 ER - TY - JOUR AU - Moran, G. J. AU - Krishnadasan, A. AU - Gorwitz, R. J. AU - Fosheim, G. E. AU - McDougal, L. K. AU - Carey, R. B. PY - 2006 DA - 2006// TI - Methicillin-resistant S. aureus infections among patients in the emergency department JO - N Eng J Med VL - 355 ID - Moran2006 ER - TY - JOUR AU - Hersh, A. L. AU - Chambers, H. F. AU - Maselli, J. H. AU - Gonzales, R. PY - 2008 DA - 2008// TI - National trends in ambulatory visits and antibiotic prescribing for skin and soft-tissue infections JO - Arch Intern Med VL - 168 ID - Hersh2008 ER - TY - JOUR AU - Pallin, D. J. AU - Egan, D. J. AU - Pelletier, A. J. AU - Espinola, J. A. AU - Hooper, D. C. AU - Camargo, C. A. PY - 2008 DA - 2008// TI - Increased US emergency department visits for skin and soft tissue infections, and changes in antibiotic choices, during the emergence of community-associated methicillin-resistant Staphylococcus aureus JO - Ann Emerg Med VL - 51 ID - Pallin2008 ER - TY - JOUR AU - Edelsberg, J. AU - Taneja, C. AU - Zervos, M. AU - Haque, N. AU - Moore, C. AU - Reyes, K. PY - 2009 DA - 2009// TI - Trends in US hospital admissions for skin and soft tissue infections JO - Emerg Infect Dis J VL - 15 ID - Edelsberg2009 ER - TY - STD TI - Guimaraes MA, Ramundo MS, Americo MA, de Mattos MC, Souza RR, Ramos-Junior ES, et al. A comparison of virulence patterns and in vivo fitness between hospital- and community-acquired methicillin-resistant Staphylococcus aureus related to the USA400 clone. Eur J Clin Microbiol Infect Dis 2014. [Epub ahead of print] ID - ref11 ER - TY - JOUR AU - Strandén, A. M. AU - Frei, R. AU - Adler, H. AU - Flückiger, U. AU - Widmer, A. F. PY - 2009 DA - 2009// TI - Emergence of SCCmec type IV as the most common type of methicillin-resistant Staphylococcus aureus in a university hospital JO - Infection VL - 37 UR - https://doi.org/10.1007/s15010-008-7430-7 DO - 10.1007/s15010-008-7430-7 ID - Strandén2009 ER - TY - JOUR AU - Casado-Verrier, B. AU - Gómez-Fernández, C. AU - Paño-Pardo, J. R. AU - Gómez-Gil, R. AU - Mingorance-Cruz, J. AU - Moreno-Alonso de Celada, R. PY - 2012 DA - 2012// TI - Community-acquired methicillin resistant Staphylococcus aureus skin and soft tissue infections in Madrid: prevalence study JO - Enferm Infecc Microbiol Clin VL - 30 ID - Casado-Verrier2012 ER - TY - JOUR AU - Spellberg, B. AU - Bartlett, J. G. AU - Gilbert, D. N. PY - 2013 DA - 2013// TI - The future of antibiotics and resistance JO - N Eng J Med VL - 368 ID - Spellberg2013 ER - TY - JOUR AU - Marwick, C. AU - Broomhall, J. AU - McCowan, C. AU - Phillips, G. AU - Gonzalez-McQuire, S. AU - Akhras, K. PY - 2011 DA - 2011// TI - Severity assessment of skin and soft tissue infections: cohort study of management and outcomes for hospitalized patients JO - J Antimicrob Chemother VL - 66 ID - Marwick2011 ER - TY - JOUR AU - Spellberg, B. AU - Boucher, H. AU - Bradley, J. AU - Das, A. AU - Talbot, G. PY - 2011 DA - 2011// TI - To treat or not to treat: adjunctive antibiotics for uncomplicated abscesses JO - Ann Emerg Med VL - 57 ID - Spellberg2011 ER - TY - JOUR AU - Chambers, H. F. AU - Moellering, R. C. AU - Kamitsuka, P. PY - 2008 DA - 2008// TI - Clinical decisions: management of skin and soft-tissue infection JO - N Engl J Med VL - 359 ID - Chambers2008 ER - TY - JOUR AU - Talbot, G. H. AU - Powers, J. H. AU - Fleming, T. R. AU - Siuciak, J. A. AU - Bradley, J. AU - Boucher, H. PY - 2012 DA - 2012// TI - Progress on developing endpoints for registrational clinical trials of community-acquired bacterial pneumonia and acute bacterial skin and skin structure infections: update from the Biomarkers Consortium of the Foundation for the National Institutes of Health JO - Clin Infect Dis VL - 55 ID - Talbot2012 ER - TY - JOUR AU - Itani, K. M. AU - Shorr, A. F. PY - 2014 DA - 2014// TI - FDA guidance for ABSSSI trials: implications for conducting and interpreting clinical trials JO - Clin Infect Dis. VL - 58 ID - Itani2014 ER - TY - JOUR AU - Gunderson, C. G. PY - 2011 DA - 2011// TI - Cellulitis: definition, etiology, and clinical features JO - Am J Med VL - 124 ID - Gunderson2011 ER - TY - JOUR AU - Pallin, D. J. AU - Binder, W. D. AU - Allen, M. B. AU - Lederman, M. AU - Parmar, S. AU - Filbin, M. R. PY - 2013 DA - 2013// TI - Clinical trial: comparative effectiveness of cephalexin plus trimethoprim-sulfamethoxazole versus cephalexin alone for treatment of uncomplicated cellulitis: a randomized controlled trial JO - Clin Infect Dis VL - 56 ID - Pallin2013 ER - TY - STD TI - US Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for Industry. Uncomplicated and complicated skin and skin structure infections - developing antimicrobial drugs for treatment (draft guidance) 1998. Available at http://www.fda.gov/ohrms/dockets/98fr/2566dft.pdf UR - http://www.fda.gov/ohrms/dockets/98fr/2566dft.pdf ID - ref22 ER - TY - STD TI - US Food and Drug Administration, Center for Drug Evaluation and Research. Guidance for industry. Acute bacterial skin and skin structure infections: developing drugs for treatment. (draft guidance) 2010 ID - ref23 ER - TY - JOUR AU - Liu, C. AU - Bayer, A. AU - Cosgrove, S. E. AU - Daum, R. S. AU - Fridkin, S. K. AU - Gorwitz, R. J. PY - 2011 DA - 2011// TI - Clinical practice guidelines by the Infectious Diseases Society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children JO - Clin Infect Dis VL - 52 ID - Liu2011 ER - TY - JOUR AU - Stevens, D. L. AU - Bisno, A. L. AU - Chambers, H. F. AU - Dellinger, E. P. AU - Goldstein, E. J. C. AU - Gorbach, S. L. PY - 2014 DA - 2014// TI - Practice guidelines for the diagnosis and management of skin and soft tissue infections JO - Clin Infect Dis VL - 59 ID - Stevens2014 ER - TY - JOUR AU - Corey, G. R. AU - Stryjewski, M. E. PY - 2011 DA - 2011// TI - New rules for clinical trials of patients with acute bacterial skin and skin-structure infections: do not let the perfect be the enemy of the good JO - Clin Infect Dis. VL - 52 ID - Corey2011 ER - TY - JOUR AU - Stryjewski, M. E. AU - Chambers, H. F. PY - 2008 DA - 2008// TI - Skin and soft-tissue infections caused by community-acquired methicillin-resistant Staphylococcus aureus JO - Clin Infect Dis. VL - 46 ID - Stryjewski2008 ER - TY - JOUR PY - 2012 DA - 2012// TI - Recommendations to the FDA for interim endpoints for clinical trials in acute bacterial skin and skin structure infections JO - Clin Infect Dis. VL - 55 ID - ref28 ER - TY - JOUR AU - Snodgrass, W. R. AU - Anderson, T. PY - 1937 DA - 1937// TI - Prontosil in the treatment of erysipelas, a controlled series of 312 cases JO - Br Med J. VL - 2 ID - Snodgrass1937 ER - TY - JOUR AU - Snodgrass, W. R. AU - Anderson, T. PY - 1937 DA - 1937// TI - Sulphanilamide in the treatment of erysipelas: a controlled series of 312 cases JO - Br Med J. VL - 2 ID - Snodgrass1937 ER - TY - STD TI - The Infectious Diseases Society of America. The Infectious Diseases Society of America’s comments on Docket #FDA-2010-D-0433; Draft guidance for industry on acute bacterial skin and skin structure infections: developing drugs for treatment 2010. [http://www.idsociety.org/uploadedFiles/IDSA/Policy_and_Advocacy/Current_Topics_and_Issues/Advancing_Product_Research_and_Development/Bad_Bugs_No_Drugs/Position_Papers/IDSA%20Comments%20re%20FDA%20ABSSSI%20Guidance%20111710.pdf UR - http://www.idsociety.org/uploadedFiles/IDSA/Policy_and_Advocacy/Current_Topics_and_Issues/Advancing_Product_Research_and_Development/Bad_Bugs_No_Drugs/Position_Papers/IDSA%20Comments%20re%20FDA%20ABSSSI%20Guidance%20111710.pdf ID - ref31 ER - TY - JOUR AU - Drusano, G. L. PY - 2012 DA - 2012// TI - Early endpoints for acute bacterial skin and skin structure infections JO - Antimicrob Agents Chemother VL - 56 ID - Drusano2012 ER - TY - JOUR AU - Moran, G. J. AU - Fang, E. AU - Corey, G. R. AU - Das, A. F. AU - Anda, C. AU - Prokocimer, P. PY - 2014 DA - 2014// TI - Tedizolid for 6 days versus linezolid for 10 days for acute bacterial skin and skin-structure infections (ESTABLISH-2): a randomised, double-blind, phase 3, non-inferiority trial JO - Lancet Infect Dis VL - 14 ID - Moran2014 ER - TY - JOUR AU - Bien, P. AU - Anda, C. AU - Prokocimer, P. PY - 2014 DA - 2014// TI - Comparison of digital planimetry and ruler technique to measure ABSSSI lesion sizes in the ESTABLISH-1 study JO - Surg Infect (Larchmt) VL - 15 ID - Bien2014 ER - TY - JOUR AU - Corey, G. R. AU - Wilcox, M. H. AU - Talbot, G. H. AU - Thye, D. AU - Friedland, D. AU - Baculik, T. PY - 2010 DA - 2010// TI - CANVAS 1: the first phase III, randomized, double-blind study evaluating ceftaroline fosamil for the treatment of patients with complicated skin and skin structure infections JO - J Antimicrob Chemother. VL - 65 ID - Corey2010 ER - TY - JOUR AU - Prokocimer, P. AU - Anda, C. AU - Fang, E. AU - Mehra, P. AU - Das, A. PY - 2013 DA - 2013// TI - Tedizolid phosphate vs linezolid for treatment of acute bacterial skin and skin structure infections: the ESTABLISH-1 randomized trial JO - JAMA VL - 309 UR - https://doi.org/10.1001/jama.2013.241 DO - 10.1001/jama.2013.241 ID - Prokocimer2013 ER - TY - JOUR AU - Rajendran, P. M. AU - Young, D. AU - Maurer, T. AU - Chambers, H. AU - Perdreau-Remington, F. AU - Ro, P. PY - 2007 DA - 2007// TI - Randomized, double-blind, placebo-controlled trial of cephalexin for treatment of uncomplicated skin abscesses in a population at risk for community-acquired methicillin-resistant Staphylococcus aureus infection JO - Antimicrob Agents Chemother VL - 51 ID - Rajendran2007 ER - TY - JOUR AU - Ruhe, J. J. AU - Smith, N. AU - Bradsher, R. W. AU - Menon, A. PY - 2007 DA - 2007// TI - Community-onset methicillin-resistant Staphylococcus aureus skin and soft-tissue infections: impact of antimicrobial therapy on outcome JO - Clin Infect Dis VL - 44 ID - Ruhe2007 ER - TY - JOUR AU - Singer, A. J. AU - Talan, D. A. PY - 2014 DA - 2014// TI - Management of skin abscesses in the era of methicillin-resistant Staphylococcus aureus JO - N Engl J Med VL - 370 ID - Singer2014 ER - TY - JOUR AU - Corey, G. R. AU - Wilcox, M. AU - Talbot, G. H. AU - Friedland, H. D. AU - Baculik, T. AU - Witherell, G. W. PY - 2010 DA - 2010// TI - Integrated analysis of CANVAS 1 and 2: phase 3, multicenter, randomized, double-blind studies to evaluate the safety and efficacy of ceftaroline versus vancomycin plus aztreonam in complicated skin and skin-structure infection JO - Clin Infect Dis VL - 51 ID - Corey2010 ER - TY - JOUR AU - Friedland, H. D. AU - O’Neal, T. AU - Biek, D. AU - Eckburg, P. B. AU - Rank, D. R. AU - Llorens, L. PY - 2012 DA - 2012// TI - CANVAS 1 and 2: analysis of clinical response at day 3 in two phase 3 trials of ceftaroline fosamil versus vancomycin plus aztreonam in treatment of acute bacterial skin and skin structure infections JO - Antimicrob Agents Chemother VL - 56 ID - Friedland2012 ER - TY - JOUR AU - Corey, G. R. AU - Kabler, H. AU - Mehra, P. AU - Gupta, S. AU - Overcash, J. S. AU - Porwal, A. PY - 2014 DA - 2014// TI - Single-dose oritavancin in the treatment of acute bacterial skin infections JO - N Engl J Med VL - 370 ID - Corey2014 ER - TY - JOUR AU - Boucher, H. W. AU - Wilcox, M. AU - Talbot, G. H. AU - Puttagunta, S. AU - Das, A. F. AU - Dunne, M. W. PY - 2014 DA - 2014// TI - Once-weekly dalbavancin versus daily conventional therapy for skin infection JO - N Engl J Med VL - 370 ID - Boucher2014 ER - TY - JOUR AU - Cofield, S. S. AU - Conwit, R. AU - Barsan, W. AU - Quinn, J. PY - 2010 DA - 2010// TI - Recruitment and retention of patients into emergency medicine clinical trials JO - Acad Emerg Med VL - 17 ID - Cofield2010 ER - TY - JOUR AU - Chen, A. E. AU - Carroll, K. C. AU - Diener-West, M. AU - Ross, T. AU - Ordun, J. AU - Goldstein, M. A. PY - 2011 DA - 2011// TI - Randomized controlled trial of cephalexin versus clindamycin for uncomplicated pediatric skin infections JO - Pediatrics VL - 127 UR - https://doi.org/10.1542/peds.2010-2053 DO - 10.1542/peds.2010-2053 ID - Chen2011 ER - TY - JOUR AU - Craft, J. C. AU - Moriarty, S. R. AU - Clark, K. AU - Scott, D. AU - Degenhardt, T. P. AU - Still, J. G. PY - 2011 DA - 2011// TI - A randomized, double-blind phase 2 study comparing the efficacy and safety of an oral fusidic acid loading-dose regimen to oral linezolid for the treatment of acute bacterial skin and skin structure infections JO - Clin Infect Dis. VL - 52 ID - Craft2011 ER - TY - JOUR AU - Manaktala, C. AU - Singh, A. K. AU - Verma, M. AU - Sachdeva, A. AU - Sharma, H. AU - Roy, A. PY - 2009 DA - 2009// TI - Efficacy and tolerability of cefditoren pivoxil in uncomplicated skin and skin structure infections in Indian patients JO - Indian J Dermatol VL - 54 ID - Manaktala2009 ER - TY - JOUR AU - Cenizal, M. J. AU - Skiest, D. AU - Luber, S. AU - Bedimo, R. AU - Davis, P. AU - Fox, P. PY - 2007 DA - 2007// TI - Prospective randomized trial of empiric therapy with trimethoprim-sulfamethoxazole or doxycycline for outpatient skin and soft tissue infections in an area of high prevalence of methicillin-resistant Staphylococcus aureus JO - Antimicrob Agents Chemother VL - 51 ID - Cenizal2007 ER - TY - JOUR AU - Giordano, P. A. AU - Elston, D. AU - Akinlade, B. K. AU - Weber, K. AU - Notario, G. F. AU - Busman, T. A. PY - 2006 DA - 2006// TI - Cefdinir vs. cephalexin for mild to moderate uncomplicated skin and skin structure infections in adolescents and adults JO - Curr Med Res Opin VL - 22 ID - Giordano2006 ER -